AU Patent

AU2015204378B2 — Modulators of pharmacokinetic properties of therapeutics

Assigned to Gilead Sciences Inc · Expires 2017-03-09 · 9y expired

What this patent protects

The present application provides for a compound of Formula IV, R1 0 A L3 R5 R 8-y1,G31lj N X-R9 O R2 R3 L3 Formula IV or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration …

USPTO Abstract

The present application provides for a compound of Formula IV, R1 0 A L3 R5 R 8-y1,G31lj N X-R9 O R2 R3 L3 Formula IV or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015204378B2
Jurisdiction
AU
Classification
—
Expires
2017-03-09
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.